Catalyst Wire Dossier Catalyst Wire Dossier

hMaxi-K gene therapy

hMaxi-K gene therapy · Urovant Sciences GmbH
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for hMaxi-K gene therapy, covering 2019-08-08 to 2019-08-08. Get the full timeline:

Most recent: Clinical Trial Update: Phase 2A Clinical Trial Evaluating the Potential Activity and Safety of hMaxi-K Gene for ED [Phase 2]

See pricing